% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Kordass:137560,
author = {T. Kordass$^*$ and C. E. M. Weber$^*$ and D. Eisel$^*$ and
A. Pane$^*$ and W. Osen$^*$ and S. Eichmüller$^*$},
title = {mi{R}-193b and mi{R}-30c-1* inhibit, whereas mi{R}-576-5p
enhances melanoma cell invasion in vitro.},
journal = {OncoTarget},
volume = {9},
number = {65},
issn = {1949-2553},
address = {[S.l.]},
publisher = {Impact Journals LLC},
reportid = {DKFZ-2018-01440},
pages = {32507-32522},
year = {2018},
abstract = {In cancer cells, microRNAs (miRNAs) are often aberrantly
expressed resulting in impaired mRNA translation. In this
study we show that miR-193b and miR-30c-1* inhibit, whereas
miR-576-5p accelerates invasion of various human melanoma
cell lines. Using Boyden chamber invasion assays the effect
of selected miRNAs on the invasive capacity of various human
melanoma cell lines was analyzed. Upon gene expression
profiling performed on transfected A375 cells, CTGF, THBS1,
STMN1, BCL9, RAC1 and MCL1 were identified as potential
targets. For target validation, qPCR, Western blot analyses
or luciferase reporter assays were applied. This study
reveals opposed effects of miR-193b / miR-30c-1* and
miR-576-5p, respectively, on melanoma cell invasion and on
expression of BCL9 and MCL1, possibly accounting for the
contrasting invasive phenotypes observed in A375 cells
transfected with these miRNAs. The miRNAs studied and their
targets identified fit well into a model proposed by us
explaining the regulation of invasion associated genes and
the observed opposed phenotypes as a result of networked
direct and indirect miRNA / target interactions. The results
of this study suggest miR-193b and miR-30c-1* as
tumor-suppressive miRNAs, whereas miR-576-5p appears as
potential tumor-promoting oncomiR. Thus, miR-193b and
miR-30c-1* mimics as well as antagomiRs directed against
miR-576-5p might become useful tools in future therapy
approaches against advanced melanoma.},
cin = {G182},
ddc = {610},
cid = {I:(DE-He78)G182-20160331},
pnm = {317 - Translational cancer research (POF3-317)},
pid = {G:(DE-HGF)POF3-317},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30197759},
pmc = {pmc:PMC6126698},
doi = {10.18632/oncotarget.25986},
url = {https://inrepo02.dkfz.de/record/137560},
}